Recent Quotes (30 days)

You have no recent quotes
chg | %

Reckitt Benckiser Group Plc news

   Watch this stock
Showing stories 1 - 10 of about 13   

Articles published

RB 6,309.00 -37.00 (-0.58%)
price chart
Prepared for the Grexit?
Despite the doom and gloom surrounding the future of Greece and the eurozone, UK plc looks like it could be in for a rude awakening.
Health scare caused by man swapping Nurofen for prescription drugs
A man has admitted sparking a nationwide health scare when he swapped packets of over-the-counter painkillers with anti-psychotic medication.
Moody's: Oil & Gas companies to benefit from higher oil prices resulting from ...
London, 22 May 2012 -- Higher oil prices that could potentially result from new US and European Union (EU) economic sanctions against Iranian oil exports would be credit-positive for international oil companies (IOCs) overall, but negative for ...
A codeine addict who contaminated packets of Nurofen Plus to fund his habit is ...
His actions cost manufacturer Reckitt Benckiser �2.4m when the painkiller was recalled. McGuire, who went to university at the age of 16, took 32 tablets of the drug each day to feed his secret addiction.
Coty Raises Offer to Acquire Avon Products to $24.75 a Share
Yesterday JAB Holdings B.V., a subsidiary of the company that controls Coty, said it plans to sell $2 billion of Reckitt Benckiser Group Plc shares to fund deals. Vienna-based Joh. A. Benckiser SE is the majority owner of Coty. Berkshire had $37.8 ...
2020 Comes Early with Reckitt Benckiser's Environmental Performance
PARSIPPANY, N.J., May 31, 2012 /PRNewswire/ -- Reckitt Benckiser (RB), a world leader in health, hygiene and home products whose portfolio includes iconic brands such as Clearasil�, Mucinex�, Lysol�, and Woolite�, today announced it has achieved a ...
Optimising Early Phase Oncology Clinical Trials in the EU
Oncology products dominate the global therapeutics market, and are on course to reach an estimated €56 billion in sales by 2015.
Tris Pharma Announces Approval of First-Ever Generic to Delsym ...
MONMOUTH JUNCTION, N.J., May 31, 2012 /PRNewswire/ -- Tris Pharma, a technology driven specialty pharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved the first-ever generic to Delsym�, ...
Pliazon� cream now available for metastatic colorectal cancer patients
London, 28th May 2012 - Today, Merck Serono announced that they will provide Pliazon�, a cream for the treatment of skin reactions, free to all UK patients undergoing anti-EGFR antibody therapy for metastatic colorectal cancer (mCRC).
Moolchand raises Rs 100 crore from Sequoia Capital
Sequoia Capital has invested in a number of healthcare companies in India, including in Vasan Healthcare Pvt. Ltd, Paras Pharmaceuticals Ltd (acquired by Reckitt Benckiser Group Plc), and Glocal Healthcare Systems Pvt. Ltd. The Moolchand funding is the ...